儿童风湿病国际相关诊治指南系列解读之一—— EULAR-ACR系统性红斑狼疮分类标准解读

2020-04-20 中国实用儿科杂志.2020,35(4):249-252.

系统性红斑狼疮(SLE)是一种以多系统损害和血清中出现自身抗体为特征的自身免疫性疾病。20多年来,其分类标准经历了不同专业协会或团体的几轮修改,每个标准具有不同的敏感性和特异性,为了更好地提高临床诊断

中文标题:

儿童风湿病国际相关诊治指南系列解读之一—— EULAR-ACR系统性红斑狼疮分类标准解读

发布机构:

发布日期:

2020-04-20

简要介绍:

系统性红斑狼疮(SLE)是一种以多系统损害和血清中出现自身抗体为特征的自身免疫性疾病。20多年来,其分类标准经历了不同专业协会或团体的几轮修改,每个标准具有不同的敏感性和特异性,为了更好地提高临床诊断的特异性和敏感性,欧洲抗风湿病联盟(European League Against Rheumatism,EULAR)联合美国风湿病学会(ACR)于2019年发布了新的SLE分类系统。文章将结合笔者的理解简要介绍该标准的应用。

相关资料下载:
[AttachmentFileName(sort=1, fileName=EULAR-ACR系统性红斑狼疮分类标准解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0088d1c0019100af, title=儿童风湿病国际相关诊治指南系列解读之一—— EULAR-ACR系统性红斑狼疮分类标准解读, enTitle=, guiderFrom=中国实用儿科杂志.2020,35(4):249-252., authorId=0, author=, summary=系统性红斑狼疮(SLE)是一种以多系统损害和血清中出现自身抗体为特征的自身免疫性疾病。20多年来,其分类标准经历了不同专业协会或团体的几轮修改,每个标准具有不同的敏感性和特异性,为了更好地提高临床诊断, cover=https://img.medsci.cn/2020528/1590670651317_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #333333;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>系统性红斑狼疮(SLE)是一种以多系统损害和血清中出现自身抗体为特征的自身免疫性疾病。20多年来,其分类标准经历了不同专业协会或团体的几轮修改,每个标准具有不同的敏感性和特异性,为了更好地提高临床诊断的特异性和敏感性,欧洲抗风湿病联盟(European League Against Rheumatism,EULAR)联合美国风湿病学会(ACR)于2019年发布了新的SLE分类系统。文章将结合笔者的理解简要介绍该标准的应用。</p> </div> </div> </div>, tagList=[TagDto(tagId=648, tagName=系统性红斑狼疮)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=648, guiderKeyword=系统性红斑狼疮, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2894, appHits=284, showAppHits=9, pcHits=519, showPcHits=2625, likes=0, shares=25, comments=9, approvalStatus=1, publishedTime=Thu May 28 22:13:02 CST 2020, publishedTimeString=2020-04-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu May 28 20:57:44 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 10:42:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=EULAR-ACR系统性红斑狼疮分类标准解读.pdf)])
EULAR-ACR系统性红斑狼疮分类标准解读.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214904, encodeId=0fd51214904fe, content=😻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Tue Apr 26 23:08:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198671, encodeId=92f711986e1c1, content=赞赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Wed Mar 02 11:18:28 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996384, encodeId=1f6b9963845a, content=批量关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:07:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996383, encodeId=9730996383f8, content=患者儿童狼疮, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:04:23 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996380, encodeId=fdd9996380f6, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:03:37 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2022-04-26 lemo003

    😻

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214904, encodeId=0fd51214904fe, content=😻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Tue Apr 26 23:08:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198671, encodeId=92f711986e1c1, content=赞赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Wed Mar 02 11:18:28 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996384, encodeId=1f6b9963845a, content=批量关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:07:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996383, encodeId=9730996383f8, content=患者儿童狼疮, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:04:23 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996380, encodeId=fdd9996380f6, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:03:37 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2022-03-02 lemo003

    赞赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214904, encodeId=0fd51214904fe, content=😻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Tue Apr 26 23:08:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198671, encodeId=92f711986e1c1, content=赞赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Wed Mar 02 11:18:28 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996384, encodeId=1f6b9963845a, content=批量关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:07:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996383, encodeId=9730996383f8, content=患者儿童狼疮, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:04:23 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996380, encodeId=fdd9996380f6, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:03:37 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-07-05 124e2832m32暂无昵称

    批量关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214904, encodeId=0fd51214904fe, content=😻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Tue Apr 26 23:08:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198671, encodeId=92f711986e1c1, content=赞赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Wed Mar 02 11:18:28 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996384, encodeId=1f6b9963845a, content=批量关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:07:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996383, encodeId=9730996383f8, content=患者儿童狼疮, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:04:23 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996380, encodeId=fdd9996380f6, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:03:37 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-07-05 124e2832m32暂无昵称

    患者儿童狼疮

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214904, encodeId=0fd51214904fe, content=😻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Tue Apr 26 23:08:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198671, encodeId=92f711986e1c1, content=赞赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=lemo003, createdTime=Wed Mar 02 11:18:28 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996384, encodeId=1f6b9963845a, content=批量关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:07:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996383, encodeId=9730996383f8, content=患者儿童狼疮, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:04:23 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996380, encodeId=fdd9996380f6, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68422522788, createdName=124e2832m32暂无昵称, createdTime=Mon Jul 05 13:03:37 CST 2021, time=2021-07-05, status=1, ipAttribution=)]
    2021-07-05 124e2832m32暂无昵称

    好好学习

    0

拓展阅读

2010 系统性红斑狼疮诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-05-01

2010 EULAR 治疗有神经精神症状的系统性红斑狼疮患者的推荐意见

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2010-12-01

2011 中国儿童系统性红斑狼疮诊疗建议

中华医学会儿科学分会免疫学组 · 2011-07-01

2014 靶向治疗系统性红斑狼疮:国际工作组推荐建议

国外风湿免疫科相关专家小组 · 2014-04-16

2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识

中国系统性红斑狼疮研究协作组(CSTAR,Chinese SLE Treatment And Research Group) · 2014-06-03